Severe drug-induced liver injury (DILI)
Hepatotoxicity · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Drugs and herbal/supplement products can cause severe hepatocellular or cholestatic injury, occasionally progressing to acute liver failure. Stopping the culprit, supportive care, and applying transplant criteria for failure are key.
Assessment
Investigations
- Detailed drug/supplement history (antibiotics, anti-TB, paracetamol, herbals)
- LFTs (pattern), coagulation/INR, glucose, ammonia
- Exclude viral/autoimmune/ischaemic causes; paracetamol level
Management
- Stop the suspected culprit drug(s)
- N-acetylcysteine for paracetamol-related (and considered in non-paracetamol acute liver failure)
- Supportive care; monitor INR, glucose and conscious level
- Apply Kings College criteria and refer early to a liver/transplant unit if failing
- Avoid further hepatotoxins; manage complications of liver failure
Drugs & doses
Stop culprit drug
N-acetylcysteine
Supportive care
Disposition
Hepatology; transplant unit if failing.
Stop the drug and watch the INR and conscious level - a rising INR with encephalopathy in DILI means refer to a transplant centre urgently.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.